Who will read my blog?

It is important to consider your audience when writing a blog so that content will resonate with the reader. Our audience is made up of a wide range of life sciences and biotech companies, industry stakeholders including government, policymakers, professional bodies, and journalists in the UK and beyond. 

The guest blogs are published in the blog section of the BIA website. Our website is visited by 133,000 users who generate nearly 400,000 page views annualy, coming from the UK (44%), United States (20%), Europe (16%), China (7%) and India (4%).

Guest blogs are often featured in our e-news - Newscast, which has more than 10,000 subscribers, and Member Insights, reserved exclusively for BIA members with over 2,500 recipients.

We also promote guest blogs across our social media channels - LinkedIn (nearly 9,000 followers) and Twitter (10,400 followers).

How should I write my blog?

Popular guest blog topics address subjects that appeal to our audience, we welcome topics surrounding access to medicines, finance/tax investment, overarching political issues, pre-clinical and clinical research, manufacturing, strategic technologies, regulatory landscapes, skills, diversity and more!

Top tips:

  • Address a clear and compelling subject: having a punchy headline and introduction will grab the reader’s attention.
  • Explain the subject to the reader: some readers will be interested in the minutiae of the issues and will require an in-depth explanation. Using hyperlinks to other blogs, articles, reports, websites, or briefings that have this detail will be beneficial.
  • Explain your connection to the topic: blogging is often a more personal form of writing, connect with your audience by demonstrating your link to and expertise on the blog’s content.
  • Include images and visuals: images can be very useful in helping you tell a story, or explain a concept, so try to include at least one or two photos or images. Please ensure you have the right to use these photos to avoid any copyright infringement.
  • Provide a headshot of the author: having a headshot-like photo of yourself is also important. Your author photo helps readers connect with you. It needs to be professional, clean, and actually looks like you. If readers know what you look like, they can find you at events.

Please note that we do not accept any over-promotional blogs.

How do I submit my blog?

Please send your blog to Alina and Erica at least three days before it is due to be published. This will give us an opportunity to proofread and come up with any suggestions we think may enhance your content.

View examples of guest blogs

CEO Update | 27 June 2022

I was delighted to see the announcement from Moderna that it has chosen the UK to base its mRNA Innovation and Technology Centre and an additional mRNA manufacturing centre. Alongside other recent investments from the likes of Fujifilm and ThermoFisher, the UK is now superbly placed to ensure the next generation of therapeutics and vaccines are developed and manufactured for the globe right here within our world-class ecosystem.

Working with the UK’s rich health data

The UK has rich and diverse health data which provides exceptional opportunities for research and innovation. Despite this opportunity, the transformative potential of health data research is far from being realised in full. Only a fraction of NHS, biomedical and health-relevant data is accessible to inform research. It can take a very long time to apply for data access and have all the relevant approvals, checks and safeguards in place to do the analysis. And once data access is granted, data can of variable quality. Read this blog by Dr James Pickett, Hub Development Manager at HDR UK about creation of large, safe data sharing initiatives across the UK.

Data saves lives: a new era for health data research?

The Department for Health and Social Care (DHSC) has published a new strategy ‘Data Saves Lives: Reshaping Health and Social Care with Data’. It seeks to drive innovation and improve efficiency across the NHS, while resetting the relationship with the public on health data. Senior Policy and Public Affairs Manager, Dr Emma Lawrence, outlines what this means for the life science sector, including our growing TechBio community.